Meagher MF, Mir MC, Minervini A, Kriegmair M, Heck M, Porpiglia F, Van Bruwaene S, Linares E, Hevia V, D'Anna M, Veccia A, Roussel E, Claps F, Palumbo C, Marchioni M, Afari J, Saitta C, Liu F, Rubio J, Campi R, Mari A, Amiel T, Checcucci E, Musquera M, Guruli G, Pavan N, Albersen M, Antonelli A, Klatte T, Autorino R, McKay RR, Derweesh IH.

Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)

Frontiers in Oncology 2023. 13: 1113246-1113246.

[doi:10.3389/fonc.2023.1113246]

Araujo-Castro, M, Pascual-Corrales, E, Alvaro, JL, Ojeda, CM, Pian, H, Ruz-Caracuel, I, Dehesa, AS, Romero, ABS, Alonso-Gordoa, T, Molina-Cerrillo, J, Dos Santos, VG.

Surgical and postsurgical management of abdominal paragangliomas and pheochromocytomas

ACTAS UROLOGICAS ESPANOLAS 2023. 47(2): 68-77.

[doi:10.1016/j.acuro.2022.05.008]

LLEDÓ GARCÍA, ENRIQUE, HEVIA PALACIOS, VITAL.

EAU Guidelines on Renal Transplantation 2023

EAU Guidelines on Renal Transplantation 2023 2023. : .

Mesnard B, Territo A, Campi R, Hevia V, Andras I, Piana A, Pecoraro A, Boissier R, Prudhomme T.

Kidney transplantation from elderly donors (> 70 years): a systematic review.

WORLD JOURNAL OF UROLOGY 2023. 41(3): 695-707.

[doi:10.1007/s00345-023-04311-4]

Subiela JD, González-Padilla DA, Huguet J, Aumatell J, Rodríguez-Faba O, Krajewski W, Feliu AH, Mínguez C, Plaza JL, Medina AA, Gajate P, Cidre MÁJ, Revilla JB, Breda A, Palou J.

Oncological and Renal Function Outcomes in Patients Who Underwent Simultaneous Radical Cystectomy and Nephroureterectomy for Synchronous or Metachronous Panurothelial Carcinoma

Urology 2023. 172: 157-164. Nº de citas: 1

[doi:10.1016/j.urology.2022.08.064]

Esteban-Villarrubia J, Torres-Jiménez J, Bueno-Bravo C, García-Mondaray R, Subiela JD, Gajate P.

Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer

Cancers 2023. 15(3): .

[doi:10.3390/cancers15030566]

Prudhomme T, Boissier R, Hevia V, Campi R, Pecoraro A, Breda A, Territo A.

Native nephrectomy and arterial embolization of native kidney in autosomal dominant polycystic kidney disease patients: indications , timing and postoperative outcomes

Minerva Urology And Nephrology 2023. 75(1): 17-30. Nº de citas: 3

[doi:10.23736/S2724-6051.22.04972-2]

Castro-Pinto, M, Lopez-Menendez, J, Sanchez-Esteban, S, Hernandez, I, Reventun, P, Rodriguez-Roda, J, Zaragoza, C, Saura, M.

Endothelial integrine-linked kinase and valvular calcification: Molecular studyof calcification in aortic valve

Cirugia Cardiovascular 2023. 30(1): 11-16.

[doi:10.1016/j.circv.2022.07.002]

Araujo-Castro M, Pascual-Corrales E, Lorca Álvaro J, Mínguez Ojeda C, Pian H, Ruz-Caracuel I, Sanjuanbenito Dehesa A, Serrano Romero AB, Alonso-Gordoa T, Molina-Cerrillo J, Gómez Dos Santos V.

Surgical and postsurgical management of abdominal paragangliomas and pheochromocytomas.

Actas Urologicas Espanolas 2023. 47(2): 68-77.

[doi:10.1016/j.acuroe.2022.08.008]

García Barreras S, Minguez Ojeda C, López Plaza JA, Arribas Terradillas S, Fernandez Conejo G, Sanz Mayayo E, Rodriguez Patron R, Burgos Revilla FJ.

How has the COVID-19 pandemic influenced prostate cancer?a tertiary single-centre analysis of oncological results, diagnosis and treatment times

Translational Andrology and Urology 2022. 11(12): 1637-1644. Nº de citas: 1

[doi:10.21037/tau-22-360]

Pozas J, Álvarez Rodríguez S, Fernández VA, Burgos J, Santoni M, Manneh Kopp R, Molina-Cerrillo J, Alonso-Gordoa T.

Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?

Cancers 2022. 14(24): .

[doi:10.3390/cancers14246071]

Simonet M, Dominguez Gutierrez A, Territo A, Prudhomme T, Campi R, Andras I, Baboudjian M, Hevia V, Boissier R.

Systematic review on oncologic outcomes on adjuvant endovesical treatment for non-muscle invasive bladder cancer in patients with solid organ transplant

WORLD JOURNAL OF UROLOGY 2022. 40(12): 2901-2910.

[doi:10.1007/s00345-022-04188-9]

Molina-Cerrillo J, Santoni M, Ruiz Á, Massari F, Pozas J, Ortego I, Gómez V, Grande E, Alonso-Gordoa T.

Epigenetics in advanced renal cell carcinoma: potential new targets.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2022. 180: 103857-103857. Nº de citas: 1

[doi:10.1016/j.critrevonc.2022.103857]

Pecoraro A, Andras I, Boissier R, Hevia V, Prudhomme T, Serni S, Breda A, Campi R, Territo A.

The learning curve for open and minimally-invasive kidney transplantation: a systematic review by the European Association of Urology Young Academic Urologists kidney transplantation working group.

Minerva Urology And Nephrology 2022. 74(6): 669-679. Nº de citas: 6

[doi:10.23736/S2724-6051.22.04909-6]

Hevia M, Fraile A, Sanz E, Artiles A, Santiago M, García-Barreras S, Fernández-Conejo G, Rodríguez-Patrón R, Burgos-Revilla J.

Does aetiology of urethral stricture influence the survival of the buccal mucosa graft?-comparative study in patients with penile urethral stricture due to lichen sclerosus vs. idiopathic group.

Translational Andrology and Urology 2022. 11(11): 1512-1522.

[doi:10.21037/tau-21-1149]

González Padilla DA, Subiela JD, Carrion DM, Esperto F, Gómez Rivas J, Khadhouri S, Mantica G, Mattigk A, Pradere B, Rodríguez Socarrás M, Segui Moya E, Teoh JY, Tortolero-Blanco L, Uçar T, Dahm P.

Evidence-based Medicine: Perceptions, Attitudes, and Skills Among European Urology Residents

European Urology Open Science 2022. 45: 44-49. Nº de citas: 1

[doi:10.1016/j.euros.2022.08.023]

Baard J, Shariat SF, Roupret M, Yoshida T, Saita A, Saltirov I, Burgos JR, Celik O, de la Rosette J, Laguna P.

Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES-UTUC registry.

WORLD JOURNAL OF UROLOGY 2022. 40(11): 2755-2763.

[doi:10.1007/s00345-022-04168-z]

Krajewski W, Aumatell J, Subiela JD, Nowak L, Tukiendorf A, Moschini M, Basile G, Poletajew S, Malkiewicz B, Giudice FD, Maggi M, Chung BI, Cimadamore A, Galosi AB, Fave RFD, D'Andrea D, Shariat SF, Hornak J, Babjuk M, Chorbinska J, Teoh JY, Muilwijk T, Joniau S, Tafuri A, Antonelli A, Panunzio A, Alvarez-Maestro M, Simone G, Mastroianni R, Laszkiewicz J, Lonati C, Zamboni S, Simeone C, Niedziela L, Candela L, Macek P, Contieri R, Hidalgo BG, Rivas JG, Sosnowski R, Mori K, Mir C, Soria F, González-Padilla DA, Faba ÒR, Palou J, Ploussard G, Rajwa P, Halon A, Laukhtina E, Pradere B, Tully K, Burgos FJ, Cidre MÁJ, Szydelko T.

Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 2022. 40(11): .

[doi:10.1016/j.urolonc.2022.06.008]